Westrock Coffee Company Reports Third Quarter 2024 Results
As it relates to the new
Third Quarter Highlights
Consolidated Results
- Net sales were
$220.9 million for the third quarter of 2024, an increase of$1.2 million , or 0.6%, compared to the third quarter of 2023. - Gross profit for the third quarter of 2024 was
$37.1 million and included$0.5 million of non-cash mark-to-market losses, compared to gross profit of$35.1 million for the third quarter of 2023, which included$1.2 million of non-cash mark-to-market losses. - Net loss for the period was
$14.3 million , compared to a net income of$16.6 million for the third quarter of 2023. The$14.3 million net loss for the third quarter of 2024 included$2.5 million of transaction, restructuring and integration expense,$7.9 million of pre-production costs related to ourConway, Arkansas extract and ready-to-drink facility (the “Conway Facility”),$4.0 million of scale-up costs related to the Conway Facility,$1.2 million of impairment charges related to our previously announced plant closures, and$5.5 million non-cash gains from the change in fair value of warrant liabilities. The$16.6 million net income for the third quarter of 2023 included$3.1 million of transaction, restructuring and integration expense,$3.0 million of pre-production costs related to our Conway Facility, and$25.1 million of non-cash gains from the change in fair value of warrant liabilities. - Consolidated Adjusted EBITDA1 for the third quarter of 2024 was
$10.3 million and included$4.0 million of scale-up costs associated with our Conway Facility. Consolidated Adjusted EBITDA for the third quarter of 2023 was$11.6 million and did not include any scale-up costs associated with our Conway Facility.
Segment Results
- Beverage Solutions segment contributed
$164.0 million of net sales and had Segment Adjusted EBITDA2 of$11.8 million for the third quarter of 2024, compared to$176.8 million and$9.9 million , respectively, for the third quarter of 2023. - Sustainable Sourcing & Traceability (“SS&T”) segment, net of intersegment revenues, contributed
$56.9 million of net sales and had Segment Adjusted EBITDA of$2.5 million for the third quarter of 2024, compared to$42.8 million and$1.7 million , respectively, for the third quarter of 2023.
______________________________
1 Consolidated Adjusted EBITDA is a non-GAAP measure. The definition of Consolidated Adjusted EBITDA is included under the section titled “Non-GAAP Financial Measures” and a reconciliation of Consolidated Adjusted EBITDA to the most comparable GAAP measure is provided in the tables that accompany this release.
2 Segment Adjusted EBITDA is a segment performance measure. While not a
Warrant Exchange
As previously disclosed, on
Board Appointment
The Company is announcing today the appointment of
2024 and 2025 Preliminary Outlook
The Company is updating its guidance to conform to its revised presentation of Consolidated Adjusted EBITDA, as discussed in the tables that accompany this release. In fiscal year 2024, the Company expects to report
In fiscal year 2025, the Company expects to report Consolidated Adjusted EBITDA of between
(i) volume growth in the Company’s core coffee business from new retail coffee customers;
(ii) new volume commitments from existing single serve customers and new single serve customer wins;
(iii) full year benefit of expense savings from cost reduction and facility consolidation efforts;
(iv) the rapid scale of our RTD can volumes beginning in the first quarter of 2025 and continuing throughout 2025, and the launch of our RTD glass bottle products in the third quarter of 2025.
Management will provide additional details regarding the 2024 and 2025 outlook on its earnings results call to be held today.
The Company is not readily able to provide a reconciliation of forecasted Consolidated Adjusted EBITDA to forecasted GAAP net income (loss) without unreasonable effort because certain items that impact such figure are uncertain or outside the Company’s control and cannot be reasonably predicted. Such items include the impacts of non-cash gains or losses resulting from mark-to-market adjustments, among others.
Conference Call Details
About
Forward-Looking Statements
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended from time to time. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, our 2024 financial outlook, our 2025 preliminary financial outlook, certain plans, expectations, goals, projections, and statements about the timing and benefits of the build-out, and our ability to sell or commit the capacity of the Company's
Contacts
Media:
Investor Contact:
Condensed Consolidated Balance Sheets (Unaudited) |
||||||||
(Thousands, except par value) | ||||||||
ASSETS | ||||||||
Cash and cash equivalents | $ | 22,359 | $ | 37,196 | ||||
Restricted cash | 10,321 | 644 | ||||||
Accounts receivable, net of allowance for credit losses of |
102,669 | 99,158 | ||||||
Inventories | 160,644 | 149,921 | ||||||
Derivative assets | 16,720 | 13,658 | ||||||
Prepaid expenses and other current assets | 23,921 | 12,473 | ||||||
Total current assets | 336,634 | 313,050 | ||||||
Property, plant and equipment, net | 438,617 | 344,038 | ||||||
116,111 | 116,111 | |||||||
Intangible assets, net | 116,968 | 122,945 | ||||||
Operating lease right-of-use assets | 61,404 | 67,601 | ||||||
Other long-term assets | 7,380 | 7,769 | ||||||
Total Assets | $ | 1,077,114 | $ | 971,514 | ||||
LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY | ||||||||
Current maturities of long-term debt | $ | 12,137 | $ | 9,811 | ||||
Short-term debt | 58,007 | 43,694 | ||||||
Accounts payable | 52,320 | 69,106 | ||||||
Supply chain finance program | 70,881 | 78,076 | ||||||
Derivative liabilities | 10,204 | 3,731 | ||||||
Accrued expenses and other current liabilities | 38,479 | 35,217 | ||||||
Total current liabilities | 242,028 | 239,635 | ||||||
Long-term debt, net | 326,122 | 223,092 | ||||||
Convertible notes payable - related party, net | 49,689 | — | ||||||
Deferred income taxes | 14,475 | 10,847 | ||||||
Operating lease liabilities | 58,507 | 63,554 | ||||||
Warrant liabilities | 729 | 44,801 | ||||||
Other long-term liabilities | 1,286 | 1,629 | ||||||
Total liabilities | 692,836 | 583,558 | ||||||
Commitments and contingencies | ||||||||
Series A Convertible Preferred Shares, |
273,938 | 274,216 | ||||||
Shareholders' Equity | ||||||||
Preferred stock, |
— | — | ||||||
Common stock, |
941 | 880 | ||||||
Additional paid-in-capital | 515,925 | 471,666 | ||||||
Accumulated deficit | (418,315 | ) | (362,624 | ) | ||||
Accumulated other comprehensive income | 11,789 | 3,818 | ||||||
Total shareholders' equity | 110,340 | 113,740 | ||||||
Total Liabilities, Convertible Preferred Shares and Shareholders' Equity | $ | 1,077,114 | $ | 971,514 | ||||
Condensed Consolidated Statements of Operations (Unaudited) |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(Thousands, except per share data) | 2024 | 2023 | 2024 | 2023 | ||||||||||||
Net sales | $ | 220,860 | $ | 219,612 | $ | 621,749 | $ | 649,748 | ||||||||
Costs of sales | 183,775 | 184,546 | 505,987 | 544,707 | ||||||||||||
Gross profit | 37,085 | 35,066 | 115,762 | 105,041 | ||||||||||||
Selling, general and administrative expense | 46,132 | 37,050 | 142,182 | 105,275 | ||||||||||||
Transaction, restructuring and integration expense | 2,538 | 3,137 | 9,901 | 12,682 | ||||||||||||
Impairment charges | 1,165 | — | 1,996 | — | ||||||||||||
(Gain) loss on disposal of property, plant and equipment | (8 | ) | 248 | 965 | 1,145 | |||||||||||
Total operating expenses | 49,827 | 40,435 | 155,044 | 119,102 | ||||||||||||
Loss from operations | (12,742 | ) | (5,369 | ) | (39,282 | ) | (14,061 | ) | ||||||||
Other (income) expense | ||||||||||||||||
Interest expense | 6,889 | 7,803 | 21,921 | 21,216 | ||||||||||||
Change in fair value of warrant liabilities | (5,481 | ) | (25,105 | ) | (7,134 | ) | (18,833 | ) | ||||||||
Other, net | (10 | ) | 510 | 223 | 1,323 | |||||||||||
(Loss) income before income taxes and equity in earnings from unconsolidated entities | (14,140 | ) | 11,423 | (54,292 | ) | (17,767 | ) | |||||||||
Income tax expense (benefit) | 84 | (5,212 | ) | 1,254 | (3,331 | ) | ||||||||||
Equity in (earnings) loss from unconsolidated entities | 35 | 14 | 145 | 80 | ||||||||||||
Net (loss) income | $ | (14,259 | ) | $ | 16,621 | $ | (55,691 | ) | $ | (14,516 | ) | |||||
Net loss attributable to non-controlling interest | — | — | — | 15 | ||||||||||||
Net (loss) income attributable to shareholders | (14,259 | ) | 16,621 | (55,691 | ) | (14,531 | ) | |||||||||
Participating securities' share in earnings | — | (3,912 | ) | — | — | |||||||||||
Accretion of Series A Convertible Preferred Shares | 88 | 93 | 262 | (249 | ) | |||||||||||
Net (loss) income attributable to common shareholders | $ | (14,171 | ) | $ | 12,802 | $ | (55,429 | ) | $ | (14,780 | ) | |||||
(Loss) earnings per common share: | ||||||||||||||||
Basic | $ | (0.16 | ) | $ | 0.15 | $ | (0.63 | ) | $ | (0.19 | ) | |||||
Diluted | $ | (0.16 | ) | $ | 0.15 | $ | (0.63 | ) | $ | (0.19 | ) | |||||
Weighted-average number of shares outstanding: | ||||||||||||||||
Basic | 88,540 | 83,437 | 88,320 | 78,203 | ||||||||||||
Diluted | 88,540 | 107,080 | 88,320 | 78,203 | ||||||||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) |
||||||||
Nine Months Ended |
||||||||
(Thousands) | 2024 | 2023 | ||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (55,691 | ) | $ | (14,516 | ) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 23,196 | 18,419 | ||||||
Impairment charges | 1,996 | — | ||||||
Equity-based compensation | 8,508 | 6,297 | ||||||
Provision for credit losses | 1,368 | 278 | ||||||
Amortization of deferred financing fees included in interest expense | 2,432 | 1,560 | ||||||
Loss on disposal of property, plant and equipment | 965 | 1,145 | ||||||
Mark-to-market adjustments | (2,692 | ) | (1,045 | ) | ||||
Change in fair value of warrant liabilities | (7,134 | ) | (18,833 | ) | ||||
Foreign currency transactions | 461 | 1,481 | ||||||
Deferred income tax expense (benefit) | 1,133 | (3,331 | ) | |||||
Other | 1,003 | 1,443 | ||||||
Change in operating assets and liabilities: | ||||||||
Accounts receivable | (4,930 | ) | 1,993 | |||||
Inventories | (7,191 | ) | (14,153 | ) | ||||
Derivative assets and liabilities | 12,685 | 4,090 | ||||||
Prepaid expense and other assets | 1,447 | (8,469 | ) | |||||
Accounts payable | (2,650 | ) | (50,254 | ) | ||||
Accrued liabilities and other | 9,071 | (1,236 | ) | |||||
Net cash used in operating activities | (16,023 | ) | (75,131 | ) | ||||
Cash flows from investing activities: | ||||||||
Additions to property, plant and equipment | (141,451 | ) | (121,545 | ) | ||||
Additions to intangible assets | (144 | ) | (147 | ) | ||||
Acquisition of business, net of cash acquired | — | (2,392 | ) | |||||
Acquisition of equity method investments and non-marketable securities | — | (1,385 | ) | |||||
Proceeds from sale of property, plant and equipment | 1,225 | 198 | ||||||
Net cash used in investing activities | (140,370 | ) | (125,271 | ) | ||||
Cash flows from financing activities: | ||||||||
Payments on debt | (151,968 | ) | (170,522 | ) | ||||
Proceeds from debt | 250,882 | 221,509 | ||||||
Payments on supply chain financing program | (121,203 | ) | (2,321 | ) | ||||
Proceeds from supply chain financing program | 114,008 | 69,787 | ||||||
Proceeds from convertible notes payable | 22,000 | — | ||||||
Proceeds from convertible notes payable - related party | 50,000 | — | ||||||
Payment of debt issuance costs | (3,329 | ) | (3,023 | ) | ||||
Payment of convertible notes payable issuance costs | (511 | ) | — | |||||
Net proceeds from (repayments of) repurchase agreements | (7,111 | ) | (8,553 | ) | ||||
Proceeds from exercise of stock options | 12 | 848 | ||||||
Proceeds from exercise of Public Warrants | — | 2,632 | ||||||
Proceeds from issuance of common stock | 635 | 118,767 | ||||||
Payment of equity issuance costs | (10 | ) | (1,000 | ) | ||||
Payment for purchase of non-controlling interest | — | (2,000 | ) | |||||
Payment for taxes for net share settlement of equity awards | (2,041 | ) | (2,977 | ) | ||||
Net cash provided by financing activities | 151,364 | 223,147 | ||||||
Effect of exchange rate changes on cash | (131 | ) | (335 | ) | ||||
Net (decrease) increase in cash and cash equivalents and restricted cash | (5,160 | ) | 22,410 | |||||
Cash and cash equivalents and restricted cash at beginning of period | 37,840 | 26,405 | ||||||
Cash and cash equivalents and restricted cash at end of period | $ | 32,680 | $ | 48,815 | ||||
Summary of Segment Results (Unaudited) |
||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||
(Thousands) | 2024 | 2023 | 2024 | 2023 | ||||||||
Beverage Solutions | ||||||||||||
Net sales | $ | 164,010 | $ | 176,818 | $ | 485,322 | $ | 547,746 | ||||
Segment Adjusted EBITDA1 | 11,752 | 9,884 | 35,797 | 29,965 | ||||||||
Sustainable Sourcing & Traceability | ||||||||||||
Net sales2 | $ | 56,850 | $ | 42,794 | $ | 136,427 | $ | 102,002 | ||||
Segment Adjusted EBITDA1 | 2,475 | 1,711 | 3,236 | 1,393 |
______________________________
1 - Segment Adjusted EBITDA is a segment performance measure. While not a
2 - Net of intersegment revenues.
Reconciliation of Net Income (Loss) to Non-GAAP Consolidated Adjusted EBITDA (Unaudited) |
||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
(Thousands) | 2024 | 2023 | 2024 | 2023 | ||||||||||||
Net (loss) income | $ | (14,259 | ) | $ | 16,621 | $ | (55,691 | ) | $ | (14,516 | ) | |||||
Interest expense | 6,889 | 7,803 | 21,921 | 21,216 | ||||||||||||
Income tax expense (benefit) | 84 | (5,212 | ) | 1,254 | (3,331 | ) | ||||||||||
Depreciation and amortization | 7,680 | 6,364 | 23,196 | 18,419 | ||||||||||||
EBITDA | 394 | 25,576 | (9,320 | ) | 21,788 | |||||||||||
Transaction, restructuring and integration expense | 2,538 | 3,137 | 9,901 | 12,682 | ||||||||||||
Change in fair value of warrant liabilities | (5,481 | ) | (25,105 | ) | (7,134 | ) | (18,833 | ) | ||||||||
Management and consulting fees ( |
— | — | — | 556 | ||||||||||||
Equity-based compensation | 3,028 | 2,439 | 8,508 | 6,297 | ||||||||||||
Impairment charges | 1,165 | — | 1,996 | — | ||||||||||||
7,937 | 3,035 | 30,115 | 6,615 | |||||||||||||
Mark-to-market adjustments | 470 | 1,160 | (2,692 | ) | (1,045 | ) | ||||||||||
Loss on disposal of property, plant and equipment | (8 | ) | 248 | 965 | 1,145 | |||||||||||
Other | 226 | 1,105 | 1,506 | 2,153 | ||||||||||||
Consolidated Adjusted EBITDA | $ | 10,269 | $ | 11,595 | $ | 33,845 | $ | 31,358 | ||||||||
Historically, the Company has presented Consolidated Adjusted EBITDA3 as excluding (i) preproduction costs it has incurred to place the
Three Months Ended | Six Months Ended | |||||||
(Thousands) | ||||||||
Consolidated Adjusted EBITDA, as presented | $ | 13,664 | $ | 24,806 | ||||
(1,230 | ) | (1,230 | ) | |||||
Consolidated Adjusted EBITDA, as revised | $ | 12,434 | $ | 23,576 | ||||
______________________________
3 In prior filings and earnings releases, “Consolidated Adjusted EBITDA” was referred to as “Adjusted EBITDA”.
Non-GAAP Financial Measures
We refer to EBITDA and Consolidated Adjusted EBITDA in our analysis of our results of operations, which are not required by, or presented in accordance with, accounting principles generally accepted in
We define “EBITDA” as net (loss) income, as defined by GAAP, before interest expense, provision for income taxes and depreciation and amortization. We define “Consolidated Adjusted EBITDA” as EBITDA before equity-based compensation expense and the impact, which may be recurring in nature, of transaction, restructuring and integration related costs, including management services and consulting agreements entered into in connection with the acquisition of
Since EBITDA and Consolidated Adjusted EBITDA are not measures calculated in accordance with GAAP, they should be viewed in addition to, and not be considered as alternatives for, net income (loss) determined in accordance with GAAP. Further, our computations of EBITDA and Consolidated Adjusted EBITDA may not be comparable to that reported by other companies that define EBITDA and Consolidated Adjusted EBITDA differently than we do.
Source: Westrock Coffee Company